A 809 bp Sau 3A -Hpa
INTRODUCTION
The application of recombinant DNA methods can provide an alternative for the production of antigens that can be used as vaccines against infection. Hepatitis B virus (HBV) DNA has been cloned in bacteria and the genes coding for the hepatitis B surface antigen (HBsAg) and the hepatitis B core antigen (HBcAg) have been identified (1) (2) (3) (4) (5) . Large amounts of HBcAg have been synthesized in Escherichia coli (1, (6) (7) (8) and Bacillus subtilis (9) ; recently HBsAg has been synthesized in yeast (10, 11) . Many investigators have tried to express HBsAg gene in E. coli and have succeeded to obtain expression as a &-galactosidase : HBsAg fusion (12) or B-lactamase : HBsAg fusion protein (1, 7) .
However, neither the direct expression of the HBsAg gene in E. coli nor the synthesis of high levels of HBsAg has been reported. Here we report success in synthesizing in E. coli materials that specifically react with an antibody against HBsAg. This is the first time that HBsAg has been directly expressed in E. coli in a nonprecursor form at a considerable level.
MATERIALS AND METHODS

Materials
Reagents were obtained from the following sources : 3-6 indolylacrylic acid (IAA), Wako Pure Chemicals; agarose, Seakem Laboratories; chloramphenicol and tetracycline, Sigma Chemical Co.; ampicillin, Takeda Chemical Industries, Ltd.; phenylmethylsulfonyl fluoride (PMSF), Calbiochem. All other chemicals were reagent grade. Bacterial strains and media Escherichia coli K-12 strains, C600 (13) and P678-54 (14) were provided from the Institute for Fermentation, Osaka and Dr. Y. Ohshima of Osaka University, respectively.
L-broth medium contained Bacto-tryptone (Difco) 10 g, yeast extract (Difco) 5 g, and NaCl 5 g per liter of distilled water. Modified M-9 medium was composed of Na 2 HPO 4 6 g, KH 2 PO 4 3 g, NaCl 0.5 g, NH 4 C1 1 g, 0.1 M MgSO 4 10 ml, 0.01 M CaCl 2 10 ml, 50 % glucose 10 ml, and 20 % Casamino Acids 50 ml per liter of distilled water. Brain heart infusion (BHI) was purchased from Difco. DNA and enzymes A plasmid pBR322 was isolated as described by Clewell (15) . A composite plasmid pHBV933 (5) containing the 3.2 kilobase (kb) Eco RI DNA fragment of the entire HBV/adw genome was purified by two cycles of ethidium bromide / CsCl gradient centrifugation from the cleared lysate of E. coll xl776/pHBV933 after amplification with chloramphenicol. The DNA sequence of HBV/adw will be described elsewhere (5).
A plasmid pMT778 carrying a tryptophan operon was kindly provided by Dr. F. Imamoto (16) . Bam HI linker (HCCGGATCCGG) and Pst I linker d(GCTGCAGC) were purchased from Takara Shuzo and Collaborative Research, Inc., respectively. Cla I linker d(CATCGATG) and Cla I adaptor df^xACGCTAW 1 " 6 chemically synthesized by the phosphotriester method (17) .
All enzymes were purchased from the following sources: Bam HI, Eco RI, Hind HI, Hpa I, Pvu H, Tag I, and T4 polynucleotide kinase, Takara Shuzo ; T4 DNA ligase, Hpa n, Sau 3A and Ava I, New England Biolabs ; Cla I, Boehringer Mannheim ; E. coli alkaline phosphatase, Worthington; Klenow's DNA polymerase I (large fragment of E. coli DNA polymerase I}, P-L Biochemicals. Enzyme reactions were carryed out under the conditions recommended by the suppliers.
Construction of expression vectors
Two Ug of plasmid pTM778 were digested with Hind m and a 5.5 kb DNA fragment containing the trp_ promoter, operator, trp_ E, and part of trg D was isolated by agarose gel electrophoresis. Two hundred ng of the 5.5 kb fragment were ligated to pBR322 (400 ng), which was previously linearized by Hind m and treated with alkaline phosphatase, with T4 DNA ligase. One ug of the resulting plasmid pTRP231 was cleaved with Pvu n and religated to give a plasmid pTRP501, in which a 5.1 kb DNA fragment from pTRP231 was removed.
Five ug of pTRP501 were digested with Cla I and Hp_a I to obtain a 2.6 kb DNA fragment. Separately, fifty ug of pTRP501 were cleaved with Hpa I and Tag I to isolate a 32 base pair (bp) DNA fragment containing the trp_ promoter (7) . Two hundred ng of the 2.6 kb Cla I -Hpa I fragment and 1.5 ng of the 32 bp Hpa I -Tag I fragment were ligated with T4 DNA ligase to form a plasmid pTRP601.
Two Mg of pBR322 were cleaved with Eco RI and Ava I, and a 1.4 kb DNA fragment containing a tetracycline resistance gene was isolated. The fragment was filled in with Klenow's DNA polymerase I, and inserted into the Pvu n site in pTRP601 to give a plasmid pTRP701. Two ug of pTRP701 was partially digested with Cla I, filled in with the DNA polymerase I, and religated with T4 DNA ligase to form a plasmid pTRP771 having one Cla I site located downstream of the Shine-Dalgarno (SD) sequence (18) succeeding the trp_ promoter. To make pTRP771 smaller, it was cleaved with Eco RI and Pst I, filled in with the DNA polymerase I, ligated to a phosphorylated Pst I linker d(GCTGCAGC), and religated to form a plasmid pTRP801.
Transformation of E. coli
The procedure of Cohen et al. (19) was used to transform E. coli K-12 derivatives with a recombinant DNA. The transformed cells were incubated at 37° C for 1 hr and poured onto L-broth agar containing 50 ug ml~ of ampicillin or 12.5 ug ml of tetracycline. Subsequent incubation was carryed out at 37 C for 16 hr.
Direct colony immunoassay of recombinants expressing the HBsAg gene
Colonies of the bacteria were grown at 37° C overnight on nitrocellulose filters supported on a BHI or L agar plate containing 12.5 ug ml of tetracycline. The filters were transferred onto a modified M-9 agar plate containing 40 ug ml of IAA, incubated at 37° C for 5-6 hr, and then treated according to the method of Kemp and 125 Cowman (20) . The pretreated CNBr papers (21) were incubated with I-labelled human anti-HBsAg antibody (0.5 uCi per paper circles of 80 mm in diameter), which was one of the reagents of an AUSRIA n-125 radioimmunoassay kit (Abbott Laboratories), washed thoroughly, and autoradiographed on Kodak Royal X-Omat films at -40° C.
Assay of HBsAg
The cells were grown in 20 ml of the modified M-9 medium at 37° C, collected every one hour, and suspended in phosphate-buffered saline (pH 7.4) containing 1 mM PMSF. The HBsAg activity of the suspension was determined by radioimmunoassay as follows. Aliquots were placed on a nitrocellulose filter, lyzed with lysozyme and the protein in the lysate was transferred to the CNBr paper (21) . Antigenic polypeptides 125 were detected by the autoradiography after reaction with I-labelled human antiHBsAg antibody as described above. The amounts were determined with a Shimadzu dual-wavelength TLC Scanner CS-910 by measuring the intensity of signals appearing on Kodak Royal X-Omat films. Purified HBsAg particles from an Alexander cell line (22) were used as a standard sample.
Radioactive-labelling and electrophoretic analysis of proteins synthesized in minicells Anucleated cells (minicells) were prepared essentially from F^ coli P678-54 (14) as q described by Kool et al. (23) . A suspension of minicells (1x10 ) was incubated for 30 min at 37° C to reduce the amount of endogenous mRNA in the minicells before 50 u Ci of L-( s)-methionine (New England Nuclear) was added in the methionine assay medium (Difco). Incubation at 37° C was continued for 30 min and terminated by adding 100 ug ml" of L-methionine and immediately cooled on ice. The minicells were washed three times by centrifugation with L-broth. Pelleted minicells were suspended in 50 u 1 of Laemmli sample buffer (24), boiled for 3 min and the supernatant was collected as the sample. Samples were electrophoresed on a 17.5 % SDS-polyacrylamide gel which was then treated for fluorography (25) , dried, and subjected to autoradiography with Kodak Royal X-Omat films at -40° C.
RESULTS
Preparation of HBsAg/adw DNA fragments
The HBsAg/adw gene was prepared from the plasmid pHBV933 (5) in the following manner. Four hundred ug of pHBV933 were cleaved with Bam HI. The reaction mixture was subjected to electrophoresis at 110 V for 2 hr using a 1.0 % agarose slab gel in 100 mM Tris-HCl containing 100 mM boric acid and 2 mM EDTA (pH8.3). A 1.4 kb DNA fragment containing the whole base sequence of the HBsAg gene was recovered from the gel by the method of McDonell et aL (26) . As shown in the restriction map of the fragment (Fig. 1) , the first Sau 3A site is located just upstream from the HBsAg gene in the fragment. So, the complete HBsAg gene was isolated by digestion with Bam HI, Hpa I, and Sau 3A as follows. Two hundred ug of the plasmid pHBV933 were digested with Bam HI and Hpa I to give a 931 bp DNA fragment, that was then partially digested with Sau 3A to isolate a 809 bp DNA fragment containing the complete HBsAg gene.
Twenty ug of the 931 bp fragment were digested with Hinc n and Xba I to isolate 744 bp and 712 bp DNA fragments, respectively. Construction of plasmids for direct expression of HBsAg/adw gene As demonstrated in Fig. 2a , two ug of the 809 bp DNA fragment were filled in with the DNA polymerase I. One ug of the resulting blunt-ended fragment and 50 ng of a phosphorylated Bam HI linker d(CCGGATCCGG) were ligated with T4 DNA ligase, and then Hpa n was added to the reaction mixture for cohesive end formation. The complete HBsAg gene was purified on a Sepharose 4B column (3 x 22 mm) equilibrated with phosphate-buffered saline (pH7.4). Two hundred ng of the purified fragment were ligated with 500 ng of Cla I -digested and alkaline phosphatase-treated pTRP801 and the ligation mixture was used to transform IL coli C600 (13) . Transformants were selected on the L agar plate containing 12.5 uS ml tetracycline. As a result, we selected an expression plasmid pTRP SS-6, in which the complete HBsAg gene was in line with the trp promoter.
As indicated in Fig. 2b , one u g of the 744 bp fragment and 50 ng of a ICG ATGCG AT \ phosphorylated adaptor dl TACGCTA] wepe Ugated with T4 DNA ligase. The resulting 758 bp fragment was purified on the Sepharose 4B column and inserted into the Cla I site of pTRP801 in a corrective orientation to form an expression plasmid pTRP SS-39.
Two u g of the 712 bp fragment were filled in with the DNA polymerase I and ligated to a phosphorylated Cla I linker d(CATCGATG). The product was cleaved with Cla I and purified on the Sepharose 4B column. To adjust the nucleotide spacing between the SD sequence and the initiation codon, five hundred ng of the resulting fragment were again filled in with the DNA polymerase I, ligated to the Cla I linker, purified on the Sepharose 4B column, and inserted into the Cla I site of pTRP801 in a corrective orientation to give an expression plasmid pTRP SS-50. Growth inhibition of recombinant containing complete HBsAg gene When the plasmid carrying the complete HBsAg gene was introduced into E. coli K-12 derivatives, two kinds of transformants were obtained. One displayed normal, and the other inhibited growth. By restriction enzyme analysis, it was found that the former had a plasmid (pTRP SS-3) in which the complete HBsAg gene was inserted in an opposite orientation for expression, and that the latter harboured the plasmid (pTRP SS-6) containing the gene in a corrective orientation.
Interestingly, the growth of transformants having the plasmid pTRP SS-39 or pTRP SS-50, in which the sequence encoding the NH.-terminal hydrophobic domain was it deleted, was not inhibited. These results suggest that the NH -terminal domain is ii responsible for the inhibition of growth. The NH. -terminus might be embedded in the E. eoli membrane and interfere with its functions.
Detection of expressed HBsAg by direct immunoassay of colonies
We tried to detect the expressed products of the HBsAg/adw gene by using the direct colony immunoassay. As shown in Fig. 3 , colonies harbouring pTRP SS-6 grown on a BHI agar plate were positive in the immunoassay after induction on an IAA-containing modified M-9 plate. In particular, E^ coli C600 (13) harbouring pTRP SS-6 (C600 / pTRP SS-6) was positive and the growth was less inhibited compared with recombinants of other strains (data not shown). When grown on the modified M-9 agar plate, the colonies containing pTRP SS-39 or pTRP SS-50 were highly positive in the direct immunoassay. In contrast, none of the colonies that contained pTRP801 or pTRP SS-3 were positive.
ELectrophoretic analysis of polypeptides produced in E. coli
To analyze the polypeptides encoded by pTRP SS-6, pTRP SS-39, or pTRP SS-50, those synthesized de novo in minicells of E. coli P678-54 (14) were labelled with L-( 5 s)-methionine. As shown in Fig. 4 , minicells containing pTRP SS-6 synthesized an additional protein corresponding to 24 K daltons, that was not detected in control cells carrying pTRP771. This value corresponds in size to the major unglycosylated polypeptide derived from HBsAg particles (27) . Similarly, minicells containing pTRP SS-39 and pTRP SS-50 also formed specific polypeptides of about 22 -23 K daltons. These values are in accordance with the molecular weight of polypeptides containing HBsAg amino acid residues 23-226 and 32-226. A preliminary analysis by western blotting using a monoclonal antibody supported the synthesis of HBsAg fragments described above. Production of HBsAg by E. coli The kinetics of intracelluar HBsAg production was studied (Fig. 5) . The HBsAg •f' Numbers on the right refer to the 21 synthesis by C600 / pTRP SS-6 began at 3 hr and approached a maximum at 7-8 hr, although the recombinant grew very slowly compared with C600 / pTRP801. The level of the HBsAg (20±5 ng/ml) varied in different experiments and was calculated to be 1.0-1.5 x 10 molecules per cell, assuming that the affinity of the HBsAg to the human antiHBsAg antibody is the same as that of the HBsAg particle. On the other hand, recombinants harbouring pTRP SS-39 and pTRP SS-50 grew almost normally and they produced considerable amounts of the HBsAg fragments (30-45 ng/ml). The quantity of the HBsAg in recombinants was roughly estimated to be about 0.001 % of the total protein. However, we may underestimate the yield of the HBsAg produced in E. coli, because the affinity of the HBsAg to the human anti-HBsAg antibody was less than that of HBsAg particle from Alexander cells used as a standard. These expression levels per culture broth of the HBsAg (20-45 ng/ml) are comparable to that of HBsAg produced under control of the yeast alcohol dehydrogenase I promoter (~ 10-25 ng/ml) (11), (7) constructed recombinant plasmids that direct the synthesis of HBsAg and found -by radioimmunoassay -that cells transformed with them were uniformly negative for HBsAg. However, the same authors reported the synthesis of a &-lactamase : HBsAg fusion polypeptide (MW 41,000) that contains an antigenic determinant found in native HBsAg; however, the level of the polypeptide varied widely in different experiments. In spite of tremendous efforts, obtaining direct expression of the HBsAg gene in E. coli has not been successful until now. This failure may be due to either rapid degradation and/or inefficient transcription.
Under the conditions described above, we constructed novel recombinant DNAs of HBsAg/adw by combining vectors with HBsAg gene fragments and finally succeeded in obtaining the expression of the complete and truncated HBsAg genes in E. coli. We first found that the E. coli carrying the complete HBsAg gene exhibits growth inhibition and produces a low level of the antigen. If the low level of production per culture broth is the consequence of interference of growth by HBsAg, the construction of plasmids that do not cause growth inhibition will be nessesary for increased production. A viral hydrophobic protein is known to inhibit the growth of E. coli, as observed in the expression of the vesicular stomatitis virus glycoprotein gene (28) . So, we prepared truncated HBsAg genes lacking the sequence encoding the NH o -terminal hydrophobic domain to recover the growth inhibition, and inserted the genes into the expression vector to give pTRP SS-39 and pTRP SS-50. The transformants harbouring these plasmids did not inhibit growth, and they expressed considerable levels of HBsAg genes. We have not yet examined the effect of removing the hydrophobic terminal region on the cell growth and the expression level. As indicated above, the HBsAg derivatives 125 produced in E^ coli were easily detected by the direct immunoassay using I-labelled human anti-HBsAg antibody. However, when the HBsAg was extracted using phosphatebuffered saline without any detergents or protein denaturants and assayed by AUSRIA n-125 kit or AUSZYME kit (Abbott Laboratories), the responses were weak. The reason for the poor interaction may be that the HBsAg derivatives are not glyeosylated (29) or that they do not form particle structures as does HBsAg produced in yeasts (10, 11) . The more definitive reason is that the HBsAg is localized in the membrane fraction and not extracted by the buffer used here.
